128 related articles for article (PubMed ID: 17886715)
21. High expression of APOBEC3G in patients infected with hepatitis C virus.
Komohara Y; Yano H; Shichijo S; Shimotohno K; Itoh K; Yamada A
J Mol Histol; 2006 Nov; 37(8-9):327-32. PubMed ID: 17036163
[TBL] [Abstract][Full Text] [Related]
22. APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection.
Pion M; Granelli-Piperno A; Mangeat B; Stalder R; Correa R; Steinman RM; Piguet V
J Exp Med; 2006 Dec; 203(13):2887-93. PubMed ID: 17145955
[TBL] [Abstract][Full Text] [Related]
23. Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses.
Esnault C; Millet J; Schwartz O; Heidmann T
Nucleic Acids Res; 2006; 34(5):1522-31. PubMed ID: 16537839
[TBL] [Abstract][Full Text] [Related]
24. Restriction of foamy viruses by APOBEC cytidine deaminases.
Delebecque F; Suspène R; Calattini S; Casartelli N; Saïb A; Froment A; Wain-Hobson S; Gessain A; Vartanian JP; Schwartz O
J Virol; 2006 Jan; 80(2):605-14. PubMed ID: 16378963
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions.
Khan MA; Goila-Gaur R; Opi S; Miyagi E; Takeuchi H; Kao S; Strebel K
Retrovirology; 2007 Jul; 4():48. PubMed ID: 17631688
[TBL] [Abstract][Full Text] [Related]
26. [Expression and subcellular localization of APOBEC3G in peripheral blood mononuclear cells and liver tissues of chronic HBV patients].
Chen H; Wang LW; Chu XG; Yan SN; Gong ZJ
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):5-8. PubMed ID: 20128960
[TBL] [Abstract][Full Text] [Related]
27. APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.
Franca R; Spadari S; Maga G
Med Sci Monit; 2006 May; 12(5):RA92-8. PubMed ID: 16641889
[TBL] [Abstract][Full Text] [Related]
28. Human APOBEC3G incorporation into murine leukemia virus particles.
Kremer M; Bittner A; Schnierle BS
Virology; 2005 Jun; 337(1):175-82. PubMed ID: 15914230
[TBL] [Abstract][Full Text] [Related]
29. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
[TBL] [Abstract][Full Text] [Related]
30. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.
Suspène R; Sommer P; Henry M; Ferris S; Guétard D; Pochet S; Chester A; Navaratnam N; Wain-Hobson S; Vartanian JP
Nucleic Acids Res; 2004; 32(8):2421-9. PubMed ID: 15121899
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional regulation of APOBEC3G, a cytidine deaminase that hypermutates human immunodeficiency virus.
Rose KM; Marin M; Kozak SL; Kabat D
J Biol Chem; 2004 Oct; 279(40):41744-9. PubMed ID: 15297452
[TBL] [Abstract][Full Text] [Related]
32. Cellular restriction factors affecting the early stages of HIV replication.
Perez O; Hope TJ
Curr HIV/AIDS Rep; 2006 Feb; 3(1):20-5. PubMed ID: 16522255
[TBL] [Abstract][Full Text] [Related]
33. APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker.
Burnett A; Spearman P
J Virol; 2007 May; 81(10):5000-13. PubMed ID: 17344295
[TBL] [Abstract][Full Text] [Related]
34. The nuclear DNA deaminase AID functions distributively whereas cytoplasmic APOBEC3G has a processive mode of action.
Coker HA; Petersen-Mahrt SK
DNA Repair (Amst); 2007 Feb; 6(2):235-43. PubMed ID: 17161027
[TBL] [Abstract][Full Text] [Related]
35. Protecting APOBEC3G: a potential new target for HIV drug discovery.
Stopak K; Greene WC
Curr Opin Investig Drugs; 2005 Feb; 6(2):141-7. PubMed ID: 15751736
[TBL] [Abstract][Full Text] [Related]
36. A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).
Schröfelbauer B; Chen D; Landau NR
Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3927-32. PubMed ID: 14978281
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of cell surface CCR5 and CD40 molecules by their ligands or by HSP70 up-regulates APOBEC3G expression in CD4(+) T cells and dendritic cells.
Pido-Lopez J; Whittall T; Wang Y; Bergmeier LA; Babaahmady K; Singh M; Lehner T
J Immunol; 2007 Feb; 178(3):1671-9. PubMed ID: 17237417
[TBL] [Abstract][Full Text] [Related]
38. Multifaceted antiviral actions of APOBEC3 cytidine deaminases.
Chiu YL; Greene WC
Trends Immunol; 2006 Jun; 27(6):291-7. PubMed ID: 16678488
[TBL] [Abstract][Full Text] [Related]
39. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
[TBL] [Abstract][Full Text] [Related]
40. Dual effect of APOBEC3G on Hepatitis B virus.
Noguchi C; Hiraga N; Mori N; Tsuge M; Imamura M; Takahashi S; Fujimoto Y; Ochi H; Abe H; Maekawa T; Yatsuji H; Shirakawa K; Takaori-Kondo A; Chayama K
J Gen Virol; 2007 Feb; 88(Pt 2):432-440. PubMed ID: 17251560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
